Sinusitis News and Research

Latest Sinusitis News and Research

Unique form of chronic sinusitis found in older patients

Older patients with a diagnosis of chronic sinusitis -- a disease of the nasal cavity and paranasal sinuses that often persists over many years -- have a unique inflammatory signature that may render them less responsive to steroid treatment, according to a new study published by Vanderbilt researchers.

23 Jan 2019

MUHC's 'Dr. House' discovers new genetic disease and the gene responsible for it

A team from the Research Institute of the McGill University Health Centre led by Dr. Donald Vinh, the RI's so-called "Dr. House" because of his research into rare diseases, has discovered a new human disease and the gene responsible for it, paving the way for the proper diagnosis of patients globally and the development of new therapies.

7 Dec 2018

Pooled analysis of Intersect ENT's steroid releasing implants in patients after frontal sinus surgery to be published

Intersect ENT, Inc., a company dedicated to transforming care for patients with ear, nose and throat conditions, today announced publication of a pooled analysis in the International Forum of Allergy & Rhinology, the official journal of the American Rhinologic Society, of the company's PROPEL Contour and PROPEL Mini steroid-releasing sinus implants showing improved outcomes of frontal sinus surgery.

16 Nov 2018

Study shows how pneumococci challenge the immune system

Pneumococci are the most common cause of respiratory tract infections, such as otitis and sinusitis, as well as of severe infections like pneumonia and meningitis.

12 Nov 2018

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

Genentech, a member of the Roche Group , announced today that the randomized Phase III CLL14 study, which evaluated fixed-duration Venclexta® in combination with Gazyva® in people with previously untreated chronic lymphocytic leukemia and co-existing medical conditions, met its primary endpoint and showed a statistically significant reduction in the risk of disease worsening or death compared to standard-of-care Gazyva plus chlorambucil.

1 Nov 2018

Novartis: Lancet publishes pioneering study of Aimovig’s efficacy in episodic migraine patients

Novartis announced today that the full data from the LIBERTY study of Aimovig (erenumab) in episodic migraine patients who had tried and failed two to four prior preventive treatments have been published in the Lancet.

23 Oct 2018

Takeda presents vedolizumab phase 3 VISIBLE 1 trial results for treatment of moderately to severely active ulcerative colitis

Takeda Pharmaceutical Company Limited today announced results from the phase 3 VISIBLE 1 clinical trial evaluating the efficacy and safety of an investigational subcutaneous formulation of the gut-selective biologic vedolizumab for maintenance therapy in adult patients with moderately to severely active ulcerative colitis who achieved clinical response* at week 6 following two doses of open-label vedolizumab intravenous induction therapy.

22 Oct 2018

Scientists perform successful trial of new antibiotic on cancer reoccurrence after surgery

SCIENTISTS fighting cancer have carried out the first successful trial of the effects of the antibiotic Doxycycline on cancer reoccurrence in patients after surgery.

3 Oct 2018

Most commonly prescribed drugs to primary care patients are not often tested

Drugs most commonly prescribed to patients seen by primary care physicians are not often tested in the patients who go to these clinics, where most people receive their care, say investigators at Georgetown University Medical Center and Yale School of Medicine.

28 Aug 2018

Location of proteins on bacterial surface can impact pathogenicity of pneumococcal strains

Successful pathogenic strains of pneumococci have two proteins that, owing to their location on the surface of the bacteria, enhance their survival and ability to cause disease, a study from Karolinska Institutet in Sweden published in Nature Communications, reports.

23 Aug 2018

Steer clear of coconut oil says Harvard Professor

In a 50 minute lecture, Dr Karin Michels Professor of Harvard’s TH Chan School of Public Health and director of the Institute for Prevention and Tumour Epidemiology at the University of Freiburg, has called coconut oil one of the “worst foods you can eat,” calling it “pure poison.”

22 Aug 2018

FDA requires safety labeling changes for fluoroquinolones to strengthen warnings on adverse reactions

The U.S. Food and Drug Administration today is requiring safety labeling changes for a class of antibiotics called fluoroquinolones to strengthen the warnings about the risks of mental health side effects and serious blood sugar disturbances, and make these warnings more consistent across the labeling for all fluoroquinolones taken by mouth or given by injection.

11 Jul 2018

Aspirin desensitization can help alleviate alcohol-induced allergies in patients with AERD

Patients who suffer from Aspirin Exacerbated Respiratory Disease often experience an additional allergic reaction when drinking alcohol, including nasal congestion, wheezing, and a runny nose.

10 Jul 2018

Tonsil and adenoid removal increases long-term risk of respiratory, allergic and infectious diseases

Tonsil and adenoid removal associated with long-term risks of respiratory, allergic and infectious diseases Removing tonsils and adenoids in childhood increases the long-term risk of respiratory, allergic and infectious diseases, according to researchers who have examined - for the first time - the long-term effects of the operations.

7 Jun 2018

Doctors use new non-invasive approach to treat nasal obstruction

Researchers at The Ohio State University Wexner Medical Center are exploring how small changes in the nasal cavity impact airflow and quality of life.

14 May 2018

FDA approves new drug to treat MS in pediatric patients

The U.S. Food and Drug Administration today approved Gilenya (fingolimod) to treat relapsing multiple sclerosis (MS) in children and adolescents age 10 years and older. This is the first FDA approval of a drug to treat MS in pediatric patients.

14 May 2018

AAE's new practice statements aim at improving patient care

Improving patient care by all providers of endodontic treatment is the goal of two practice statements approved by the American Association of Endodontists' Board of Directors at its annual meeting in Denver this week.

26 Apr 2018

Acclarent introduces real-time, 3D navigation system for ENT procedures

Acclarent, Inc., part of the Johnson & Johnson Medical Devices Companies and a leader in developing minimally-invasive Ear, Nose & Throat technologies, today announced the U.S. commercial launch of TruDi, a real-time, three-dimensional navigation system for ENT procedures performed in the operating room and surgeon office.

From Johnson & Johnson 25 Apr 2018

Patient's mucus may help predict type of chronic sinusitis

By April, nearly one-third of the U.S. is already experiencing high pollen levels while the weather and temperatures continue to fluctuate, aggravating sinus symptoms. A patient's mucus may predict the type of his or her chronic sinusitis, which could help doctors determine whether surgery or medical treatments can produce the best outcomes, according to a recently published Vanderbilt study.

9 Apr 2018

Study uncovers special receptor that protects against asthma, allergies

A special receptor on cells that line the sinuses, throat and lungs evolved to protect mammals from developing a range of allergies and asthma, according to a study from researchers at Johns Hopkins Bloomberg School of Public Health.

27 Feb 2018

Sinusitis News and Research

Latest Sinusitis News and Research

Unique form of chronic sinusitis found in older patients

MUHC's 'Dr. House' discovers new genetic disease and the gene responsible for it

Pooled analysis of Intersect ENT's steroid releasing implants in patients after frontal sinus surgery to be published

Study shows how pneumococci challenge the immune system

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

Novartis: Lancet publishes pioneering study of Aimovig’s efficacy in episodic migraine patients

Takeda presents vedolizumab phase 3 VISIBLE 1 trial results for treatment of moderately to severely active ulcerative colitis

Scientists perform successful trial of new antibiotic on cancer reoccurrence after surgery

Most commonly prescribed drugs to primary care patients are not often tested

Location of proteins on bacterial surface can impact pathogenicity of pneumococcal strains

Steer clear of coconut oil says Harvard Professor

FDA requires safety labeling changes for fluoroquinolones to strengthen warnings on adverse reactions

Aspirin desensitization can help alleviate alcohol-induced allergies in patients with AERD

Tonsil and adenoid removal increases long-term risk of respiratory, allergic and infectious diseases

Doctors use new non-invasive approach to treat nasal obstruction

FDA approves new drug to treat MS in pediatric patients

AAE's new practice statements aim at improving patient care

Acclarent introduces real-time, 3D navigation system for ENT procedures

Patient's mucus may help predict type of chronic sinusitis

Study uncovers special receptor that protects against asthma, allergies

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Sinusitis News and Research

Latest Sinusitis News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in